SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-007711
Filing Date
2023-03-24
Accepted
2023-03-24 09:00:56
Documents
15
Period of Report
2023-03-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20230323_8k.htm   iXBRL 8-K 27198
2 EXHIBIT 99.1 ex_492481.htm EX-99.1 71389
7 logo01.jpg GRAPHIC 13993
  Complete submission text file 0001437749-23-007711.txt   279728

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20230323.xsd EX-101.SCH 4078
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20230323_def.xml EX-101.DEF 13570
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20230323_lab.xml EX-101.LAB 17787
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20230323_pre.xml EX-101.PRE 13537
9 EXTRACTED XBRL INSTANCE DOCUMENT govx20230323_8k_htm.xml XML 4405
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 23757840
SIC: 2834 Pharmaceutical Preparations